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A72-year-oldmale presents with a large asymptomatic aneurysm of his left popliteal artery.He has a history of noninsulin
dependent diabetes, hyptertension, and a prior history of a percutaneous intervention for a coronary artery stenosis. He
is anatomically and physiologically a candidate for surgical or endovascular repair of his aneurysm. The following debate
attempts to resolve whether open repair remains the gold standard for the treatment of popliteal artery aneurysms.
(J Vasc Surg 2010;51:271-6.)Popliteal artery aneurysms (PAAs) account for approx-
imately 70% of all peripheral aneurysms. The actual inci-
dence is estimated to be less than 0.1%; consequently, no
single center would expect to generate a large volume of
clinical experience in any given year.1,2 The elective repair
of asymptomatic PAAs is generally undertaken to prevent
the clinical sequelae of arterial embolization, thrombosis,
or, less commonly, rupture with subsequent risk to limb
and life. The indications for repair are not well defined.
However, diameter greater than 2 cm to 3 cm, particularly
in those aneurysms with a heavy thrombus load or with
chronic distal tibial artery embolic occlusion is generally
considered an acceptable indication for repair.3-7
The surgical management of PAAs has been in evolu-
tion for centuries and was described as early as the third
century AD in Greece. The Antyllus technique consisted of
tourniquet control of the circulation, proximal and distal
ligation of the popliteal aneurysm, evacuation of thrombus
from within the aneurysm, and ligation of side branches of
the popliteal aneurysm. Despite many modifications of
technique over the centuries, surgical intervention was
initially associated with a significant risk to limb and life.
The morbidity and mortality associated with open repair
led many in the 18th and 19th century to attempt other
forms of therapy. Such therapies consisted of external com-
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doi:10.1016/j.jvs.2009.09.060pression and other modalities intended to cause thrombosis
of the aneurysm. In the early part of the 20th century,
Rudolph Matas described obliterative endoaneurysmora-
phy and, 20 years ago, Edwards described PAA exclusion
and revascularization with a vein bypass graft.4,7,8
More recently, experience with endovascular surgery
expanded following Parodi’s description of the use of an
endovascular stent graft for the repair of abdominal aortic
aneurysms.9,10 The widespread adoption of endovascular
aneurysm repair was only later followed and generally sup-
ported by randomized controlled trials.11-13 This changing
treatment paradigm coincided with increasingly prevalent
endovascular approaches for peripheral arterial occlusive
disease. Percutaneous therapy is now often considered as
the first treatment option and may be the preferred option
for patients who might not otherwise be considered for
surgery for occlusive disease, given the associated surgical
morbidity and risk.14-18 The increasing prevalent role of
endovascular therapies for peripheral arterial disease and
the relative success of endovascular therapies for aortic
aneurysmal disease have led to endovascular applications
for the management of patients with PAAs (Figs 1 and 2).
OPEN REPAIR REMAINS THE GOLD
STANDARD (DR. RANDY MOORE)
Prior to the incorporation of endovascular techniques
into the modern vascular surgeon’s armamentarium, the
notion of early technical success as a valid measure for
outcome did not exist. Surgical techniques and surgical
outcomes for the major vascular procedures used to treat
vascular surgical pathology were compared with bench-
mark long-term results in order to determine efficacy and
safety. Reliability was the key feature of a successful opera-
tive strategy. Webster’s dictionary defines reliable as:
1: suitable or fit to be relied on: dependable
2: giving the same result on successive trials
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in terms of successful vascular surgical care. As the volume
of minimally interventional work has increased, so has our
willingness to accept less reliable procedures with shorter-
term success. Studies with 1 year follow-up results are now
touted as intermediate or midterm outcomes. This is per-
haps best exemplified by the current interest in the use of
endovascular techniques for the treatment of PAAs.
At the 28th Charing Cross Vascular Symposium held in
London, England in the Spring of 2006, a poll of the
Fig 1. Axial images of large left popliteal artery aneurysm.
Fig 2. Three-dimensional image of a left popliteal artery aneurysm.attendees was undertaken after a debate session focused onPAA repair in order to assess the potential impact of endo-
vascular techniques on PAA treatment. The overwhelming
majority (79%) of the primarily surgical audience felt that
endovascular techniques would not offer a reliable outcome
for the treatment of this pathology. What was their reason-
ing? Simply put, open repair offers the patient with PAA a
more reliable, more durable method for the treatment of
their disease.19 There is an extensive body of literature that
supports this.
A retrospective analysis of data from 123 United States
Veterans Affairs Medical Centers including 583 open op-
erations for PAA in 537 patients from 1994 to 2005 was
completed as part of the National Surgical Quality Im-
provement Program.20 This represents the largest reported
North American series for PAA.Despite the fact that 88% of
these patients were ASA Class 3 or 4, the 30-day mortality
rate was only 1.4%, with a low 6.3% arterial-specific com-
plication rate requiring reintervention. Unadjusted patient
survival was 92.6% at 1 year and 86.1% at 2 years. The limb
salvage rate for these surviving patients was 99% at 30 days,
97.6% at 1 year, and 96.2% at 2 years. Dependent preoper-
ative functional status did worsen the 2 year limb salvage
rate; however, at 2 years, 88.2% of these patients still had an
intact limb.
Likewise, an August 2007 report of data from the
Swedish Vascular Registry documented the outcomes of
571 patients (717 limbs) operated for PAA and followed
for a mean of 7.2 years.21 In 26 legs or 3.6% of this cohort,
PAA was treated with endovascular techniques. The au-
thors state that these small numbers precluded scientific
analysis, however one-quarter of the legs treated with en-
dovascular techniques were either converted to a bypass or
were amputated at  1 year. In contrast, limb salvage for
the open surgical cohort was 81% at follow-up. One-third
of patients with the medial approach technique developed
further aneurysm expansion. This high expansion rate post-
ligation is a critical observation that will further limit the
long-term success of endovascular techniques, since the
feeding branch vessels within the sac cannot be easily
addressed during endograft repair. The posterior open
approach in the Swedish study offered a lower re-expansion
rate of 8.3%. Other authors have also observed a benefit for
the posterior approach in terms of outcome. A series of 30
aneurysms in 24 patients treated with the posterior ap-
proach to PAA over 22 years were reported with a median
follow-up of 22 months.22 Primary patency, primary as-
sisted patency, and secondary patency rates were 92.2%,
95.8%, and 95.8% at follow-up, respectively, with a limb
salvage rate of 100%.
Another 358 PAAs in 289 patients, 21% of who had
acute ischemia, were reported by Mayo Clinic investigators
with a mean follow-up of 4.2 years.23 Remarkably, 32% of
these patients underwent prosthetic repair. Peri-operative
mortality was observed only in the acute ischemia group
(1%), as was early amputation (8%). Five-year overall pri-
mary and secondary patency rates were 76% and 87% , and
were much higher in the venous conduit cohort (85% and
94%) vs the prosthetic cohort (50 and 63%). The 5-year
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group). Preoperative thrombolysis reduced the risk of am-
putation in acutely ischemic Class II patients (96% vs 69%).
Seven recurrent PAAs required reintervention due to ex-
pansion or rupture. The authors concluded that a venous
conduit with endoaneurysmoraphy to eliminate the risk of
re-expansion remains the gold standard for PAA repair.
Their observations were further supported by a long-
term review of 48 patients having surgical repair of 63 PAAs
and followed for over 10 years.24 A total of 45 PAAs were
treated with ligation and bypass, while 18 underwent repair
with interposition grafting. Although 25% of PAAs treated
required late re-interventions, the 5-year primary graft pa-
tency, secondary graft patency, limb salvage, and patient
survival rates were 75%, 95%, 98%, and 81%, respectively. At
10 years, 66% of these grafts remained primarily patent.
This compares with the 56% 14-month overall patency
rates reported in one of the earliest series of endovascular
repair for PAA.25 In this early series, 11 patients had a total
of 12 PAAs treated with covered stents. At 1 and 12
months, these investigators observed 47% primary patency
and 75% secondary patency rates. Subsequent improve-
ments in stent design did not appear to improve the out-
comes for these patients. A series of 23 PAAs treated with
the Hemobahn endovascular device demonstrated a 22%
early occlusion rate, with a 74% primary patency at 1 year.26
Even experienced endovascular centers struggle with this
new technology, with mechanical failure of the devices
likely due to the extreme motion stresses placed upon these
endografts across the point of maximal flexion during
activity.27
Dr Eric Verhoeven and his center in Groeningen de-
scribed 57 PAAs treated with the Hemobahn device, in-
cluding 5 PAAs with acute occlusion and ischemia.28 Dur-
ing a mean follow-up of 24 months, 21% of these devices
occluded, with primary and secondary patency rates of 80%
and 90% at 1 year and 77% and 87% at 2 years. A follow-up
report in Vascular News for the 2007 Charing Cross meet-
ing described an overall 5-year primary patency rate of 70%,
and a secondary patency of 79%. The results were improved
with the addition of routine clopidogrel treatment after
PAA endovascular repair, but do not compare with the
results of larger series of open repair with longer-term
follow-up.
Another 56 PAA repairs with a mean follow-up of 16.5
months were reported in 2006, including 15 patients with
endovascular PAA repair.29 Although the authors con-
cluded that the retrospective review of these two cohorts
demonstrated similar outcomes with respect to primary and
secondary patency and survival rates, the groups were pro-
foundly different in terms of patient selection. The majority
of patients with open repair in this series were disadvan-
taged in that their intervention was for symptoms (54% vs
13%, P  .05) or acute ischemia (12% vs 0%, P  .05). In
addition, over 25% of the open surgical cohort had pros-
thetic graft placement, even though one-third of patients
had single-vessel run-off. The authors are to be com-
mended on their excellent technical success with openrepair under these circumstances! In addition, 20% of the
endovascular cohort had endoleaks, putting their repair at
risk for long-term failure due to further sac enlargement or
rupture.
The only prospective study comparing open and endo-
vascular repair for the treatment of PAA reported similar
outcomes at a mean follow-up of 46 months for the two
modalities of treatment, with shorter operative times and
length of stay for the endovascular group.30 However, the
study was flawed by the authors’ self-confessed lack of
power (only 15 patients in each treatment arm), and by the
use of an inferior conduit: below-knee prosthetic graft in
27.6% of the open-repair treatment group. Despite this
significant bias against open repair, 100% primary patency
was observed for the open group vs. 86.7% for the endo-
vascular group at 12 months. Furthermore, during the
same time period, the authors completed another 18 open
surgical PAA repairs outside of the study inclusion criteria
for patients with acute ischemia or poor runoff. The study
therefore only reports on the selected 65% of the PAA
patients that were randomized at the institution.
Finally, a meta-analysis of published studies comparing
endovascular and open surgical outcomes for PAA treat-
ment documented no significant differences in long-term
primary patency rates between the two types of repair, but
observed an 18-fold increased risk for re-intervention (odds
ratio [OR], 18.80; P  .03), and a five-fold increased risk
for 30-day graft thrombosis (OR, 5.05; P  .06) in the
endovascular group. The authors conclude that with cur-
rent technology, it is difficult to justify endovascular treat-
ment for PAA.31
In summary, endovascular repair intuitively may seem
to be an ideal approach for patients with PAA in order to
minimize the impact of open surgical morbidity. However,
the abundance of small endovascular series from single
centers, and the lack of large and/or long-term series to
support this notion, coupled with the reported inferior
patency rates compared with large and long-term series for
open repair, and the difficulty in addressing the significant
PAA endoleak and re-expansion rates after exclusion, cur-
rently renders the endovascular technique less than ideal for
all but the most physiologically intolerant of patients. In
short, endovascular repair for PAA is not reliable enough to
be considered the standard for repair. Further improve-
ments in prosthetic bypass technology including heparin-
bonded ePTFE grafts32 will only serve to improve open
reconstruction options and results for open PAA repair.
Open surgical repair remains the gold standard.
OPEN REPAIR IS NO LONGER THE GOLD
STANDARD: THE CASE FOR ENDOVASCULAR
REPAIR (DR. ANDREW HILL)
Surgical interventions, like most forms of therapy in
medicine, are in constant evolution. This evolution is the
result of continuous treatment evaluation and technical
improvements to optimize patient outcome.With time, old
maxims and accepted standards of care tend to fall by the
wayside as superior treatment methods are introduced.
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cally prescribed for multiple ailments, have been relegated
to the annals of history as more disease-specific therapies
have evolved. In more modern times, minimally invasive
general surgery has rapidly replaced traditional open surgi-
cal techniques. The introduction of technology such as
laparoscopic cholecystectomy, spurred on by public de-
mand, has often outpaced the ability to critically evaluate
the new procedures with prospective randomized con-
trolled trials. For the most part, however, the potential
benefits of such minimally invasive procedures have been
confirmed with time. These benefits include reduction in
patient discomfort, postoperative complications and dis-
ability, hospital length of stay, tissue injury, postoperative
inflammatory response, and postoperative immunosup-
pression.33,34 Although laparoscopic techniques were only
introduced to general surgeons in 1987, the subsequent 20
years has seen a rapid dissemination of minimally invasive
laparoscopic techniques to all areas of general surgery for
most practicing general surgeons.
It is important to recognize that the average asymp-
tomatic patient being considered for elective popliteal ar-
tery intervention tends to be an older male (96%) with
multiple co-morbidities. This should influence treatment
options due to operative risk and overall reduced life ex-
pectancy. Almost half of such patients will have bilateral
PAAs and a significant proportion of patients can have
synchronous aneurysms with the potential requirement for
multiple interventions.2,21 Traditional open surgical repair
often requires multiple and/or long leg incisions with the
subsequent risk of wound complications, leg edema, pro-
longed hospital stay, slow return to normal function, and
associated risk of systemic complications. These factors
would tend to favor the development of a minimally inva-
sive option for repair of a PAA.
When staging an argument for endovascular aneurysm
repair, one should consider whether or not a true and tested
gold standard currently exists for open surgical repair, the
relative morbidity of open surgery, and the long-term
patency and limb salvage rates for open and endovascular
aneurysm repair.
The introduction of new technology often requires
evaluation against the accepted standard of care or the
traditional standard of therapy. It can be argued, however,
that a single well-defined open surgical procedure does not
exist for comparison with endovascular aneurysm repair.
Much has changed in the world during the 40 years that
followed Edwards’ publication8; however, the optimal
open surgical approach for repair of a PAA has not been
standardized. Options have included simple bypass of the
aneurysm, aneurysm exclusion and vein bypass, and bypass
by lateral or posterior approach. Additionally, there are
differences of opinion regarding the benefit of ligating the
geniculate branches of the PAA.2,21,24,35-37 When one
considers the various available open surgical approaches, a
quick survey of PubMed demonstrates the complete lack of
prospective randomized controlled studies documenting a
particular benefit for one method of open surgical repairover another. The elective surgical management available
for patients with a PAA is varied, has been changing with
time, and has not been subjected to randomized compari-
son when considering one open surgical recommendation
over another. A reasonable question persists as to whether
or not a true open surgical gold standard operation exists
for the management of patients with PAAs.
When offering patients elective therapy for an asymp-
tomatic PAA, one must keep in mind the patient’s age,
co-morbidities, life expectancy, the potential presence of
synchronous aneurysms, and the possible requirement for
multiple interventions. Such surgery is prophylactic; conse-
quently, surgical risk should be minimal. Open surgical
repair of a PAA generally requires multiple incisions in the
leg, dissection and disruption of the anatomy of the popli-
teal fossa, groin incisions, and a risk for wound and systemic
complications. In one nationwide study of patients treated
surgically for popliteal artery aneurysm, a 2% limb loss per
year was documented following open surgical repair. There
were significant rates of perioperative complications such as
neurologic, infection, seroma, and hematoma.21 Open sur-
gical repair of PAAs is associated with at least a 1.6%
operativemortality rate.24Despite open repair, there can be
a 30% risk of aneurysmal expansion over time, even without
obvious flow from geniculate branches. There is even po-
tential for rupture of a previously bypassed PAA.35,38 Com-
partment syndrome has been reported as a long-term com-
plication following bypass of a PAA.39 Postoperative leg
swelling has been documented in over 50% of patients
following bypass surgery.40 Various reports of bypass sur-
gery in the leg have documented up to a 10% to 20% risk of
surgical site infection.41
An endovascular approach to repair of a PAA is attrac-
tive because of the potential to minimize patient morbidity,
duration of hospitalization, and recovery time. These are all
important issues, particularly in a frail patient population
that may require multiple interventions. However, the pa-
tency of endovascular stent grafts in the popliteal artery
should not be inferior to that obtained with open bypass
surgery.
The feasibility of an endovascular approach to the man-
agement of patients with a PAA was demonstrated in early
case reports and small clinical series.42-51 Although a variety
of devices were described, most reported good early tech-
nical success without significant morbidity, no mortality,
and short hospital stays. Concern was expressed, however,
about the undocumented long-term patency of this new
approach.
The surgical data available on long-term outcome for
open repair of PAAs is not large, given the relatively low
incidence of the problem and the difficulty for any one
center to accumulate a large experience. However, data
does exist. Two relatively large contemporary case series of
open surgical repair for 356 PAAs have documented 5-year
primary patency rates of 75% to 85% for autogenous vein
grafts.23,24 These rates compare favorably with a systematic
review of literature that included 2,445 PAA repairs that
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patency rate for vein grafts.1
Case series of endovascular PAA repair have suggested
that these minimally invasive grafts may not have inferior
patency results when compared with the historical controls
for open surgical repair. A recent study of 23 endovascular
procedures for PAAs demonstrated a 93% primary and
100% secondary 1-year patency rate.52 Another relatively
large study of 35 PAAs demonstrated 75% 3-year primary
patency and 83.2% secondary patency.53 In a larger study of
73 PAAs treated with endovascular therapy, Tielliu demon-
strated 70% 5-year primary and 76% secondary patency
rates.54 The 5-year primary patency rates improved over
time to 80% with clinical experience and the addition of
clopidogrel to postoperative patient management. A retro-
spective cohort study of open (n  41) and endovascular
(n  15) PAA repair has demonstrated similar 1 to 2 year
patency rates.29 These early data suggest at least noninferi-
ority for patency rates for endovascular stent graft repair of
PAAs compared with various traditional open surgical
repairs.
A prospective comparative study of open (n  27) and
endovascular (n  21) repair demonstrated no primary or
secondary patency differences out to 72 months of follow-
up.55 This study included data from a randomized con-
trolled study of open and endovascular popliteal aneurysm
repair that did not demonstrate a patency difference be-
tween the two approaches out to 3 years of follow-up.30
Lovegrove has published a meta-analysis of all comparative
studies of open (n  104) and endovascular (n  37)
popliteal aneurysm repair. This study demonstrated similar
patency rates between the two techniques, although the
reintervention rate for endovascular grafts was higher than
that required for open surgery.
In summary, endovascular repair of PAAs has replaced
open repair as the gold standard, as it has comparable
patency without the associated local and systemic compli-
cations associated with open surgery.
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As endovascular stent grafts gained a firm foothold in the
treatment of aortic aneurysms, we have seen the continued appli-
cation of this therapy to aneurysmal disease in other vascular beds.
The popliteal artery is no exception and offers unique challenges
compared with the aorta. In the current debate, Drs Hill and
Moore provide logical arguments for and against an endovascular
approach to popliteal artery aneurysm (PAA) repair.
There are several knowledge gaps regarding PAA manage-
ment. First of all, little is known of the natural history of untreated
aneurysms. As a result, any treatment recommendation based on
aneurysm diameter is less robust than with aortic aneurysms. The
indications for treatment differ as well, with PAAs rarely rupturing
and more commonly causing thrombosis, embolization, or com-
pressive symptoms. Most of these complications can be potentially
prevented by open or endovascular repair. However, differing from
the aorta, little has been described regarding PAA regression
following endovascular repair. As a result, compressive symptoms
caused by popliteal aneurysms are best treated with an open repairA consistent argument against new endovascular therapies is
the relative absence of long term data, as Dr Moore clearly states.
In this climate, it’s a wonder that any new endovascular technology
takes hold as we continue to subject it to more intense surveillance
than the open surgical “gold standard” and initially select higher-
risk individuals to treat. Additionally, these evaluations occur when
the technology is still maturing and, as Dr Hill states, the “gold
standard” for open PAA repair is ill-defined and comprises several
operations that could easily be the topic of another debate. For
these reasons, the approximately similar patency and limb salvage
rates with endovascular and open PAA repair is encouraging and
generally offers support for an endovascular approach, rather than
discouraging.
A clear advantage of an endovascular approach is the reduction
in the morbidity more often associated with open repair, namely
local wound healing and infection-related complications. There is
not much debate around this issue nor the reality that endovascular
therapy of popliteal aneurysms is here to stay and is attractive to
many of our patients.
